Changes in central serotonergic function as a correlate of duration of illness in paranoid schizophrenia

Psychiatry Research

Volumn 110, Issue 1, 2002, Pages 9-17

  Angelopoulos, Elias K ^a   Markianos, Manolis ^a   Daskalopoulou, Eugenia G ^a   Hatzimanolis, John ^a   Tzemos, John ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Clomipramine; Dopamine; Haloperidol; Prolactin; Schizophreniform disorder; Serotonin

Indexed keywords

CLOMIPRAMINE; HALOPERIDOL; PROLACTIN;

ADAPTATION; ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE DURATION; DOPAMINERGIC SYSTEM; DRUG RESPONSE; HORMONE DETERMINATION; HUMAN; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; NEUROTRANSMISSION; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; SCHIZOPHRENIFORM DISORDER; SCORING SYSTEM; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE; TIME;

ADOLESCENT; ADULT; BRAIN; CHRONIC DISEASE; CLOMIPRAMINE; DOPAMINE; HALOPERIDOL; HUMANS; MALE; PROGNOSIS; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA, PARANOID; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 0037094050     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(02)00037-9     Document Type: Article

References (34)

1. Clomipramine enhances prolactin and growth hormone response to L-tryptophan
2. Decreased 5-HT-mediated prolactin release in major depression
3. Neuroendocrine responsivity to clomipramine challenge test in neuroleptic naive psychotic patients before and after treatment with haloperidol
4. Serotonin, schizophrenia and antipsychotic drug action
5. Binding of typical and atypical antipsychotics to 5-HT1 and 5-HT2 sites: Clozapine potently interacts with 5-HT1c sites
6. Neuroendocrine tests of monoamine function in man: A review of basic theory and its application to the study of depressive illness
7. The effects of intravenous clomipramine on neurohormones in normal subjects
8. Prolactin response to neuroleptics in normal and schizophrenic subjects
9. Effects of antidepressant drugs on different receptors in the brain
10. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia
11. Differential prolactin responses to haloperidol and TRH in normal adult men
12. Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms
13. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
14. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems
15. Abnormal prolactin response to haloperidol challenge in men with schizophrenia
16. M-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia
17. Comparison of growth hormone and prolactin stimulation induced by chlorimipramine and desimipramine in man in connection with chlorimipramine metabolism
18. Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats
19. Duration of psychosis and outcome in first-episode schizophrenia
20. Prolactin responses to haloperidol in drug-free and treated schizophrenic patients
21. Adverse effects of fenfluramine in treatment refractory schizophrenia
22. Increased brain dopamine and dopamine receptors in schizophrenia
23. Clinical studies on the mechanism of action of clozapine: The dopamine hypothesis of schizophrenia
24. The dopamine hypothesis of schizophrenia: A review
25. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics
26. Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia
27. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: A placebo controlled study
28. Monoamines and schizophrenia
29. Antipsychotic drug doses and neuroleptic/dopamine receptors
30. The prolactin response to fenfluramine in schizophrenia is associated with negative symptoms
31. The dopamine hypothesis of schizophrenia: Focus on the dopamine receptor
32. Tritiated LSD binding in frontal cortex in schizophrenia
33. Component structure of the Positive and Negative Syndrome Scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders